Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
15.38
-0.29 (-1.85%)
At close: Mar 27, 2026, 4:00 PM EDT
14.50
-0.88 (-5.72%)
After-hours: Mar 27, 2026, 7:35 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.23 billion as of March 27, 2026. Its market cap has increased by 222.56% in one year.
Market Cap
1.23B
Enterprise Value
892.73M
1-Year Change
222.56%
Ranking
Category
Stock Price
$15.38
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.23B, an increase of 45.58%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.23B | 20.53% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.26B |
| Immatics | 1.26B |
| MoonLake Immunotherapeutics | 1.24B |
| AtaiBeckley | 1.22B |
| ORIC Pharmaceuticals | 1.21B |
| Wave Life Sciences | 1.20B |
| Olema Pharmaceuticals | 1.19B |
| DBV Technologies | 1.18B |